Alfasigma to acquire Intercept Pharmaceuticals (ICPT) for $19/share streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Alfasigma to Acquire Intercept Pharmaceuticals (ICPT) for $19 00 per Share in Cash streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Shares of Intercept Pharmaceuticals Inc. were set to soar Tuesday, after the biopharmaceutical company announced an agreement to be acquired by Italy’s.
Alfasigma to Acquire Intercept Pharmaceuticals for $19 00 per Share in Cash, Expanding the Global Footprint of Alfasigma Via a Leader in Rare and Serious Liver Diseases streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
The acquisition will help boost Alfasigma’s gastroenterology and hepatology pipeline, all while giving it access to Intercept’s lead candidate Ocaliva.